[ Price : $8.95]
FDA accepts for review an Elevar Therapeutics NDA for rivoceranib, an oral tyrosine kinase inhibitor in combination with camrelizu...[ Price : $8.95]
FDA warns Mumbai, India-based Centaur Pharmaceuticals about CGMP deviations in its manufacturing of active pharmaceutical ingredie...[ Price : $8.95]
FDA warns San Jose, CA-based Outset Medical it is illegally marketing two medical devices associated with hemodialysis.[ Price : $8.95]
FDA gives Catalent a four-page Form FDA-483 after inspecting the firms Bloomington, IN manufacturing facility 5/4-12.[ Price : $8.95]
Quidel Cardiovascular recalls the Quidel Triage Cardiac Panel after reports of inaccurate tests showing lower-than-expected tropon...[ Price : $8.95]
FDA updates its final guidance entitled Qualification of Medical Device Development Tools (MDDTs).[ Price : $8.95]
Former FDA chief counsel Dan Troy joins Berkeley Research Group in the firms Washington, DC office as a managing director in its ...[ Price : $8.95]
FDA approves an AstraZeneca BLA for Beyfortus (nirsevimab-alip) for preventing Respiratory Syncytial Virus lower respiratory tract...